Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD

[1]  A. Wolk,et al.  Long-term consumption of fruits and vegetables and risk of chronic obstructive pulmonary disease: a prospective cohort study of women. , 2018, International journal of epidemiology.

[2]  C. Bai,et al.  Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-κB signaling pathway. , 2017, Journal of thoracic disease.

[3]  T. H. Nguyen,et al.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.

[4]  R. Bowler,et al.  Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice , 2017, Scientific Reports.

[5]  R. Bowler,et al.  Gene and metabolite time-course response to cigarette smoking in mouse lung and plasma , 2017, PloS one.

[6]  P. Zhao,et al.  Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations , 2017, Bioscience reports.

[7]  I. Rahman,et al.  Myofibroblast differentiation and its functional properties are inhibited by nicotine and e-cigarette via mitochondrial OXPHOS complex III , 2017, Scientific Reports.

[8]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[9]  D. Fitzmaurice,et al.  Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study. , 2016, International journal of epidemiology.

[10]  J. Wedzicha,et al.  Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD , 2016, PloS one.

[11]  COPDGene Investigators.  Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD , 2016 .

[12]  E. Regan,et al.  Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD , 2016, PLoS genetics.

[13]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[14]  R. Bischoff,et al.  HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity , 2016, Biochemical pharmacology.

[15]  D. Mannino,et al.  The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys. , 2016, Annals of the American Thoracic Society.

[16]  R. Holle,et al.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.

[17]  H. Bao,et al.  Effects of resveratrol and genistein on nuclear factor-κB, tumor necrosis factor-α and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease , 2016, Molecular medicine reports.

[18]  B. Nicholas,et al.  Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis. , 2016, American journal of respiratory and critical care medicine.

[19]  H. Rossiter,et al.  Impaired Lung Mitochondrial Respiration Following Perinatal Nicotine Exposure in Rats , 2016, Lung.

[20]  Emma L. Schymanski,et al.  MetFrag relaunched: incorporating strategies beyond in silico fragmentation , 2016, Journal of Cheminformatics.

[21]  P. Barnes,et al.  Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin. , 2016, American journal of respiratory and critical care medicine.

[22]  R. Chen,et al.  An acetyl-L-carnitine switch on mitochondrial dysfunction and rescue in the metabolomics study on aluminum oxide nanoparticles , 2015, Particle and Fibre Toxicology.

[23]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[24]  R. Crystal,et al.  Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers , 2015, PloS one.

[25]  Russell P. Bowler,et al.  Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung. , 2015, American journal of respiratory and critical care medicine.

[26]  M. Neuhouser,et al.  Targeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adults. , 2015, Food & function.

[27]  Weiliang Qiu,et al.  The metabolomics of asthma control: a promising link between genetics and disease , 2015, Immunity, inflammation and disease.

[28]  R. Bowler,et al.  Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. , 2015, American journal of respiratory and critical care medicine.

[29]  Kwanjeera Wanichthanarak,et al.  Genomic, Proteomic, and Metabolomic Data Integration Strategies , 2015, Biomarker insights.

[30]  E. Ford,et al.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. , 2015, Chest.

[31]  Meilan K. Han,et al.  The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes , 2014, Respiratory Research.

[32]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[33]  Edwin K Silverman,et al.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene , 2014, Respiratory Research.

[34]  E. Wouters,et al.  Influence of diet and obesity on COPD development and outcomes , 2014, International journal of chronic obstructive pulmonary disease.

[35]  M. Armstrong,et al.  Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis , 2014, Journal of visualized experiments : JoVE.

[36]  J. Corhay,et al.  [Phenotypes in chronic obstructive pulmonary disease]. , 2014, Revue medicale de Liege.

[37]  Takao Shimizu,et al.  Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells , 2014, Journal of Lipid Research.

[38]  David Gomez-Cabrero,et al.  Data integration in the era of omics: current and future challenges , 2014, BMC Systems Biology.

[39]  M. Borchers,et al.  Second hand smoke and COPD: lessons from animal studies , 2013, Front. Physiol..

[40]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[41]  Charmion Cruickshank-Quinn,et al.  MSPrep - Summarization, normalization and diagnostics for processing of mass spectrometry-based metabolomic data , 2014, Bioinform..

[42]  Tomer Shlomi,et al.  Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia , 2013, Molecular systems biology.

[43]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[44]  R. Bowler,et al.  The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[45]  Nichole Reisdorph,et al.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. , 2013, American journal of respiratory cell and molecular biology.

[46]  Travis J Cohoon,et al.  Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. , 2013, Cancer discovery.

[47]  M. Armstrong,et al.  New sample preparation approach for mass spectrometry-based profiling of plasma results in improved coverage of metabolome. , 2013, Journal of chromatography. A.

[48]  A. Bielawska,et al.  Plasma Sphingolipids and Lung Cancer: A Population-Based, Nested Case–Control Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[49]  T. Tsuji,et al.  Undernutrition in Patients with COPD and Its Treatment , 2013, Nutrients.

[50]  E. Pniewska,et al.  The Involvement of Phospholipases A2 in Asthma and Chronic Obstructive Pulmonary Disease , 2013, Mediators of inflammation.

[51]  J. D’Armiento,et al.  Second hand smoke and COPD: lessons from animal studies , 2013, Front. Physiol..

[52]  I. Petrache,et al.  The involvement of sphingolipids in chronic obstructive pulmonary diseases. , 2013, Handbook of experimental pharmacology.

[53]  J. Riley,et al.  Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD. , 2012, Molecular bioSystems.

[54]  S. Shapiro,et al.  Emerging genetics of COPD , 2012, EMBO molecular medicine.

[55]  Yong-chang Sun,et al.  Phenotypes of chronic obstructive pulmonary disease , 2012 .

[56]  E. Slate,et al.  Overcoming the Effects of Matrix Interference in the Measurement of Urine Protein Analytes , 2012, Biomarker insights.

[57]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[58]  Chronic obstructive pulmonary disease among adults--United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[59]  Richard C Boucher,et al.  Elevated airway purines in COPD. , 2011, Chest.

[60]  Timothy M. D. Ebbels,et al.  Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA , 2011 .

[61]  R. Murphy,et al.  MALDI imaging MS of phospholipids in the mouse lung[S] , 2011, Journal of Lipid Research.

[62]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[63]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[64]  Egon L. Willighagen,et al.  The Chemical Translation Service—a web-based tool to improve standardization of metabolomic reports , 2010, Bioinform..

[65]  Markus R. Wenk,et al.  Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase* , 2010, The Journal of Biological Chemistry.

[66]  Matthias Müller-Hannemann,et al.  In silico fragmentation for computer assisted identification of metabolite mass spectra , 2010, BMC Bioinformatics.

[67]  Kazuki Saito,et al.  Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. , 2009, Analytical chemistry.

[68]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[69]  O. Uzun,et al.  Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.

[70]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[71]  S. Johnston,et al.  Pathophysiology of viral-induced exacerbations of COPD , 2007, International journal of chronic obstructive pulmonary disease.

[72]  B. Grant,et al.  Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[73]  D. Lynch,et al.  Phenotypes of Chronic Obstructive Pulmonary Disease , 2007, COPD.

[74]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[75]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[76]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[77]  Steven Mennerick,et al.  An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[78]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[79]  M. Bevan,et al.  CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection , 2004, Nature Immunology.

[80]  Kazuki Saito,et al.  Potential of metabolomics as a functional genomics tool. , 2004, Trends in plant science.

[81]  J. E. Scott.  The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development , 2004, Tobacco Induced Diseases.

[82]  Shin Ishii,et al.  A Bayesian missing value estimation method for gene expression profile data , 2003, Bioinform..

[83]  W. Bernhard,et al.  Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. , 2002, American journal of respiratory cell and molecular biology.

[84]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[85]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[86]  J. Goerke,et al.  Pulmonary surfactant: functions and molecular composition. , 1998, Biochimica et biophysica acta.

[87]  Peter Gehr,et al.  Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant , 1992 .

[88]  P. Seglen,et al.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[89]  A. Bearn,et al.  Hereditary Deficiency of Serum α1-Antitrypsin , 1964, Science.